Click on a filter below to refine your search. Remove a filter to broaden your search.
In a large study, there were lower odds of neonatal mortality associated with vaccination.
Those who are partially vaccinated and unvaccinated face the same increased risk, whereas boosted and fully vaccinated adults fare best.
A model shows the vaccine tied to the prevention of 110,000 deaths and a resulting $30.4 billion direct healthcare cost savings.
An efficacy of 92% was found among at-risk COVID-19-unvaccinated individuals with type 1 diabetes.
In early data, the new Pfizer COVID-19 boosters marshal antibodies against newer omicron variants.
Findings show no significant reduction in primary end point, MACE for those receiving vaccine after acute coronary syndromes
No significant difference was seen in hospitalization for pneumonia or influenza or in hospitalization for any cause or mortality.
The odds of invasive mechanical ventilation and death significantly increased for those with RSV versus vaccinated COVID and flu.
IgG anti-spike antibodies were undetectable in ~20% with immunosuppression who had received three or more COVID-19 vaccines.
With its application, the company included early results of a study that involved 10,000 people.